These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15502995)

  • 1. Does the early adopter of drugs exist? A population-based study of general practitioners' prescribing of new drugs.
    Dybdahl T; Andersen M; Søndergaard J; Kragstrup J; Kristiansen IS
    Eur J Clin Pharmacol; 2004 Nov; 60(9):667-72. PubMed ID: 15502995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study.
    Dybdahl T; Andersen M; Kragstrup J; Kristiansen IS; Søndergaard J
    Br J Clin Pharmacol; 2005 Nov; 60(5):526-33. PubMed ID: 16236043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early discontinuation: more frequent among general practitioners with high levels of prescribing.
    Hansen DG; Gichangi A; Vach W; Felde LH; Larsen J
    Eur J Clin Pharmacol; 2007 Sep; 63(9):861-5. PubMed ID: 17618428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant drug use in general practice: inter-practice variation and association with practice characteristics.
    Hansen DG; Søndergaard J; Vach W; Gram LF; Rosholm JU; Kragstrup J
    Eur J Clin Pharmacol; 2003 Jun; 59(2):143-9. PubMed ID: 12721774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion of new drugs in Danish general practice.
    Steffensen FH; Sørensen HT; Olesen F
    Fam Pract; 1999 Aug; 16(4):407-13. PubMed ID: 10493713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoption of new drugs by physicians: a survival analysis.
    Garjón FJ; Azparren A; Vergara I; Azaola B; Loayssa JR
    BMC Health Serv Res; 2012 Mar; 12():56. PubMed ID: 22401169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.
    Buusman A; Kragstrup J; Andersen M
    Eur J Clin Pharmacol; 2005 Oct; 61(9):651-6. PubMed ID: 16187132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician and practice characteristics associated with the early utilization of new prescription drugs.
    Tamblyn R; McLeod P; Hanley JA; Girard N; Hurley J
    Med Care; 2003 Aug; 41(8):895-908. PubMed ID: 12886170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting general practitioners' decisions to adopt new prescription drugs - cohort analyses using Australian longitudinal physician survey data.
    Zhang Y; Méndez SJ; Scott A
    BMC Health Serv Res; 2019 Feb; 19(1):94. PubMed ID: 30728010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion of innovations: treatment of Alzheimer's disease in Germany.
    Ruof J; Mittendorf T; Pirk O; von der Schulenburg JM
    Health Policy; 2002 Apr; 60(1):59-66. PubMed ID: 11879945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care physicians' adoption of new drugs is not associated with their clinical interests: a pharmacoepidemiologic study.
    Dybdahl T; Søndergaard J; Kragstrup J; Kristiansen IS; Andersen M
    Scand J Prim Health Care; 2011 Jun; 29(2):117-21. PubMed ID: 21510719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide variation in the number of different drugs prescribed by general practitioners. A prescription database study.
    Bjerrum L; Bergman U
    Scand J Prim Health Care; 2000 Jun; 18(2):94-8. PubMed ID: 10944063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing early prescribers of newly marketed drugs in Canada: a population-based study.
    Kozyrskyj A; Raymond C; Racher A
    Eur J Clin Pharmacol; 2007 Jun; 63(6):597-604. PubMed ID: 17380324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How conducting a clinical trial affects physicians' guideline adherence and drug preferences.
    Andersen M; Kragstrup J; Søndergaard J
    JAMA; 2006 Jun; 295(23):2759-64. PubMed ID: 16788131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia.
    Cutts C; Tett SE
    Eur J Clin Pharmacol; 2003 Mar; 58(11):761-6. PubMed ID: 12634983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.
    Muijrers PE; Janknegt R; Sijbrandij J; Grol RP; Knottnerus JA
    Eur J Clin Pharmacol; 2004 Dec; 60(10):739-46. PubMed ID: 15517226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical care and its relationship to prescribing behaviour of general practitioners.
    Muijrers PE; Grol RP; Sijbrandij J; Janknegt R; Knottnerus JA
    Pharm World Sci; 2006 Oct; 28(5):302-8. PubMed ID: 17111244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor analysis improves the selection of prescribing indicators.
    Skyggedal Rasmussen HM; Søndergaard J; Sokolowski I; Kampmann JP; Andersen M
    Eur J Clin Pharmacol; 2006 Nov; 62(11):953-8. PubMed ID: 17024487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the uptake of new medicines in secondary care - a literature review.
    Chauhan D; Mason A
    J Clin Pharm Ther; 2008 Aug; 33(4):339-48. PubMed ID: 18613851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the drug prescriptions to children by Italian paediatricians and general practitioners.
    Clavenna A; Sequi M; Bonati M
    Eur J Clin Pharmacol; 2010 May; 66(5):519-24. PubMed ID: 20130846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.